Research Round Up: The Path of a Moonshot

Did you know that since 1999, Susan G. Komen® Austin has contributed more than $5M to breast cancer research?  As an Affiliate Network, Susan G. Komen has invested more than $889M in breast cancer researchers across 49 states and 20 countries. The Komen Affiliate Network is second only to the federal government in funding for breast cancer research.

President Obama has announced just this week a cancer “moonshot”, calling for the United States to become the first nation to eradicate cancer.  In response, Dr. Judith Salerno, President and CEO of Susan G. Komen stated in her Huffington Post blog piece, “…the cancer community is willing, it is able, and it is more than ready to run this last mile in mankind’s long journey against a cunning killer.”

Just as the race to the moon was complete with incremental successes that led to an ultimate victory, the path to eliminating breast cancer is now a very real possibility, due in large part to Komen.  Take a look at what Komen has done specifically for the breast cancer research community since its inception in 1982.

1. By the numbers
Research dollars raised by the Komen Affiliate Network have funded:
-2400 research grants in 49 states and 20 countries
-460 clinical trials
-300 research advocates
-60 partnerships and collaborations
-60 scientific conferences

 2. Survival
In 1980, the five-year relative survival rate for women diagnosed with early stage breast cancer was about 74 percent. Today, it’s 99 percent.  Today, there are more than 3 million breast cancers survivors in the U.S.

3. Metastatic Breast Cancer
While the breast cancer survival rate has improved, statistics show that as many as 30% of all early stage breast cancers will become metastatic.  To date, Komen has invested more than $147 million in over 370 research grants and 35 clinical trials focused on MBC.  In addition, Komen founded the Metastatic Breast Cancer Alliance, in partnership with a wide variety of breast cancer organizations.  Through these efforts, Komen is dedicated to understanding MBC, as well as advancing research working with the metastatic community at the national level to find better, more effective treatments through research and to meet the needs of the metastatic patients and families.

4. More research
The federal government now devotes more than $850 million each year to breast cancer research, treatment and prevention, compared to $30 million in 1982.  This year, Komen will contribute over $44M to breast cancer research and continue to be the largest private funder of breast cancer research in the U.S., with 50% of all funding specifically targeting MBC.  (

While Komen Austin makes an incredible local impact through the community health partners that it funds each year, it is important to note that the organization also plays a dynamic role in fighting breast cancer on a global scale through research.


Throughout the year, the Komen Austin Blog will bring you an in depth look at the research that Komen funds.  For more information on Komen Research, please visit the “We Fund Research” page.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s